Altria’s third-quarter results showcased significant growth in its oral tobacco products and a strategic focus on expanding reduced-risk offerings.
“The smokeable products segment delivered solid operating companies income growth behind the resilience of Marlboro,” said Altria’s CEO Billy Gifford, “and in the oral tobacco products segment, our MST [moist smokeless tobacco] brands continued to drive profitability while On! maintained momentum in the marketplace.”
